(Q36288753)

English

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging (English)

1 reference

Europe PubMed Central

13 August 2017

Primary systemic amyloidosis

1 reference

based on heuristic

inferred from title

Efstathios Kastritis

1

object named as

E Kastritis

1 reference

Europe PubMed Central

13 August 2017

Athanasios Dimopoulos

3

object named as

M A Dimopoulos

1 reference

Europe PubMed Central

13 August 2017

Evangelos Eleutherakis-Papaiakovou

4

object named as

E Eleutherakis-Papaiakovou

1 reference

Europe PubMed Central

13 August 2017

author name string

M Gavriatopoulou

2

1 reference

Europe PubMed Central

13 August 2017

N Kanellias

5

1 reference

Europe PubMed Central

13 August 2017

M Roussou

6

1 reference

Europe PubMed Central

13 August 2017

C Pamboucas

7

1 reference

Europe PubMed Central

13 August 2017

S T Toumanidis

8

1 reference

Europe PubMed Central

13 August 2017

E Terpos

9

1 reference

Europe PubMed Central

13 August 2017

publication date

5 June 2015

1 reference

Europe PubMed Central

13 August 2017

Blood Cancer Journal

1 reference

Europe PubMed Central

13 August 2017

5

1 reference

Europe PubMed Central

13 August 2017

e319

1 reference

Europe PubMed Central

13 August 2017

copyright license

Creative Commons Attribution 4.0 International

1 June 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1038/bcj.2015.45

0 references

Osteo-articular manifestations of amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Myeloma bone disease: pathophysiology and management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Destructive bone lesions in primary amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

30 September 2017

Systemic light chain amyloidosis: an update for treating physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Osteoprotegerin concentrations and prognosis in acute ischaemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4648482

22 September 2018

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2015.45

21 January 2018

Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2015.45

21 January 2018

Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenstrom macroglobulinaemia

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2015.45

21 January 2018

Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/26047389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BCJ.2015.45

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36288753&oldid=1980245589"